Baylor College of Medicine: GlyNAC supplementation reverses aging hallmarks in aging humans
August 18, 2022
August 18, 2022
HOUSTON, Texas, Aug. 18 (TNSjou) -- The Baylor College of Medicine issued the following news:
A randomized, double blind human clinical trial conducted by researchers at Baylor College of Medicine reveals that supplementation with GlyNAC - a combination of glycine and N-acetylcysteine - improves many age-associated defects in older humans and powerfully promotes healthy aging. This is relevant because until now, there have been no solutions toward improving many of these age-related . . .
A randomized, double blind human clinical trial conducted by researchers at Baylor College of Medicine reveals that supplementation with GlyNAC - a combination of glycine and N-acetylcysteine - improves many age-associated defects in older humans and powerfully promotes healthy aging. This is relevant because until now, there have been no solutions toward improving many of these age-related . . .